scai Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Search past issues
Search products and services

The Bristol Myers Squibb Foundation and National Medical Fellowships today have entered into a partnership aimed at improving diversity in clinical trials. Leveraging $100 million...

source: Bristol Myers Squibb

SCAI, working with two coalitions representing the medical community, successfully lobbied Congress to overturn harmful cuts proposed by the Centers for Medicare and Medicare Services (CMS). Signed by the President...

source: SCAI

The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed COVID‐19. Although there is an association between cardiovascular disease and COVID‐19,...

source: Catheterization and Cardiovascular Interventions

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is highly infectious, carries significant morbidity...

source: Catheterization and Cardiovascular Interventions

High-risk patients with atrial fibrillation may have better outcomes with left atrial appendage (LAA) closure with the Amplatzer Amulet device (Abbott) than with direct oral anticoagulant treatment, an observational analysis suggests. The rate of ischemic stroke through...

source: TCTMD

Same-day discharge (SDD) after percutaneous coronary intervention can provide value to both patients and healthcare providers. However, knowing when SDD is the right choice — and when it isn’t — can be especially challenging.

source: Cardiovascular Business News


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to SCAI This Week

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of SCAI? Yes   No
Privacy Policy